PGEN - Precigen Inc

Buy Momentum: Bearish

Recent News

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug

Zacks Commentary • 3 weeks ago • score: 0.52

Precigen stock soars 144% in August after FDA approval of Papzimeos, the first treatment for adults with recurrent respiratory papillomatosis.

Bullish

This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Kennametal ( NYSE:KMT ) , Salesforce ( NYSE:CRM )

Benzinga • 1 month ago • score: 0.51

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. CIBC analyst Robert Catellier upgraded the rating for The Williams Companies, Inc.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.

52W High

$5.22

52W Low

$0.65

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.82

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

9.14

EV/EBITDA (<8 favorable)

-3.31

EV/Revenue (<3 favorable)

286.77

P/S (TTM) (<3 favorable)

299.35

P/B (<3 favorable)

7.25

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

10.47%

Institutions (25–75% balanced)

66.81%

Shares Outstanding

297,973,000

Float

150,441,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

4,340,000

Gross Profit (TTM)

-52,667,000

EPS (TTM)

-0.41

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-32.54%

ROE (TTM) (>15% strong)

-6.68%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.19

Momentum

Bearish momentum

Value

0.4904

0.5762

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025